Translational Cancer Medicine

|

MRes

|

Part Time, Full Time

| Admissions status: Closed
Translational Cancer Medicine enables you to gain detailed knowledge and understanding of research methods applied to rational drug design, clinical study design, molecular and cell biology, tumour immunology, genetics and cancer imaging. Practical experience gained through two six-month laboratory rotations.

Graduate student in lab
KEY BENEFITS
  • The range of topics including advanced imaging methods is unique for this translational cancer programme
  • The sponsoring laboratories and departments all have international standing and have agreed to closely supervise the trainees
  • Recently released data from the Higher Education Funding Council for England (Hefce) shows that King’s College London is equal top in England (with Queen Mary, University of London) for its PhD completion rates. This programme will potentially select candidates for the PhD programme within the Division of Cancer Studies.
KEY FACTS
Programme leader/s
Prof Tony Ng, Programme Director
Awarding institution
King's College London
Credit value (UK/ECTS equivalent)
UK 180/ECTS 90
Duration
One year FT, September to September; two year PT option available to Medics working in the UK.
Location
Guy's Campus and/or St Thomas' Campus and/or Denmark Hill Campus.
Student destinations
Future PhD studies. Clinical and non-clinical academic careers in cancer medicine.
Year of entry 2015
Offered by